Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Panayiotis, Tsaftaridis"'
Autor:
Theodoros P. Vassilakopoulos, Maria Panagiota Arapaki, Panagiotis T Diamantopoulos, Maria K. Angelopoulou, Gianpaolo Nadali, Gerasimos Tsourouflis, Maria Moschogiannis, Maria Dimopoulou, Marina Siakantaris, Xanthi Yiakoumis, Flora Kontopidou, Christina H. Kalpadakis, Gabriela Gainaru, John V. Asimakopoulos, Maria Dimou, Sotirios Sachanas, Marie-Christine Kyrtsonis, Panayiotis Tsaftaridis, Eleni Plata, Eleni Variami, Nora-Athina Viniou, Giovanni Pizzolo, Andreas H. Sarris, Kostas Konstantopoulos, Panayiotis Panayiotidis, Gerassimos Pangalis
Publikováno v:
Blood. 140:12016-12017
Autor:
Eleni Lalou, Vasileios I. Telonis, Anna Zannou, Pantelis Tsirkinidis, Alexander Kanellopoulos, Angeliki Stefanou, John Meletis, Evangelos Terpos, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Athanasios Papatheodorou, Zacharoula Galani, Georgios Boutsikas, Maria K. Angelopoulou, Anastasia Meletiou, Theodoros P. Vassilakopoulos, Nora-Athina Viniou, Panayiotis Tsirigotis, Panayiotis Tsaftaridis
Publikováno v:
European Journal of Haematology. 100:131-139
OBJECTIVES As the interaction between hematopoietic stem cells (HSCs) and endosteal and endothelial niches in HSCs homing is essential, we aimed to study bone turnover and angiogenesis in 29 patients with lymphoma/multiple myeloma undergoing hematopo
Autor:
Panayiotis Tsaftaridis, Theodoros P. Vassilakopoulos, Maria Dimou, Aspasia Koudouna, Theodoros Iliakis, Vasileios Pardalis, Panayiotis Panayiotidis, Sotiria Kalyva, Paraskevi Papaioannou, Marie-Christine Kyrtsonis, Maria K. Angelopoulou, Catherin Bitsani
Publikováno v:
Leukemialymphoma. 60(12)
Ibrutinib (IB) revealed high efficacy and safety profile in phase 2/3 chronic lymphocytic clinical trials. Emerging real-world-data shows similar response and survival, but higher discontinuation rates due to adverse events (AEs). We present retrospe
Autor:
Kyriaki Petevi, John Meletis, Loula Papageorgiou, Eleni Plata, Glafcos Kelepesis, Theodoros P. Vassilakopoulos, Panayiotis Tsaftaridis, Maria K. Angelopoulou, John V. Asimakopoulos, Catherine Koutsi, Konstantinos Konstantopoulos
Publikováno v:
Leukemia & Lymphoma. 58:1743-1746
The implication of the promyelocytic leukemia–retinoid acid receptor alpha (RARα) [PML-RARα] fusion transcript in the pathogenesis of the acute promyelocytic leukemia (APL) formed the basis for the...
Autor:
Panagiotis Panagiotidis, C. Pontikoglou, Maria K. Angelopoulou, Christina Kalpadakis, T.P. Vassilakopoulos, D. Rontogiannis, Panayiotis Tsaftaridis, Aglaia Dimitrakopoulou, P Korkolopoulou, Eliana Konstantinou, Helen A. Papadaki, Maria Roumelioti, Gerasimos Pangalis, M. Psylaki, M.-C. Kyrtsonis, Georgios Boutsikas, Maria Ximeri, Maria Moschogiannis, Pantelis Tsirkinidis, Flora N. Kontopidou, Theodoros Iliakis, M. Befani, Sotirios Sachanas, Vasileios I. Telonis, Marina P. Siakantaris, Xanthi Yiakoumis, Efstathios Koulieris
Publikováno v:
Hematological Oncology. 37:223-224
Autor:
T.P. Vassilakopoulos, M. Befani, G. Butsikas, Sotirios Sachanas, Maria Moschogiannis, Xanthi Yiakoumis, Efstathios Koulieris, Maria K. Angelopoulou, Theodoros Iliakis, Maria N. Dimopoulou, Maria Ximeri, P Korkolopoulou, Christina Kalpadakis, Panayiotis Tsaftaridis, Aglaia Dimitrakopoulou, Maria Roumelioti, M. Psylaki, Pantelis Tsirkinidis, Helen A. Papadaki, C. Pontikoglou, I. Asimakopoulos, Flora N. Kontopidou, Marina P. Siakantaris, I. Konstantinou, Gerasimos Pangalis, D. Rontogiannis, Panagiotis Panagiotidis
Publikováno v:
HemaSphere. 3:575
Autor:
Eleni Plata, Panayiotis Tsaftaridis, Theodora Papadaki, Christina Kalpadakis, Gerassimos A. Pangalis, Xanthi Yiakoumis, Maria K. Angelopoulou, Helen E. Papadaki, Penelope Korkolopoulou, Maria Moschogiannis, Stella I. Kokoris, Marina P. Siakantaris, Marie-Christine Kyrtsonis, Flora N. Kontopidou, Maria N. Dimopoulou, Theodoros P. Vassilakopoulos, Sotirios Sachanas, Evagelia M. Dimitriadou
Publikováno v:
The Oncologist. 18:190-197
Background. Treatment of splenic marginal zone lymphoma (SMZL) patients is not standardized. Recent data suggest that rituximab is highly effective and could be considered as initial therapy. Aim. To assess the efficacy of rituximab monotherapy in a
Autor:
Pagona Flevari, Maria N. Dimopoulou, Xanthoula Yiakoumis, Konstas Konstantopoulos, Kyriaki Petevi, Gabriella Gainaru, Maria Dimou, Panayiotis Tsaftaridis, Eleni Plata, Nora-Athina Viniou, Alexandros Kanellopoulos, George Boutsikas, Katerina Koutsi, Loula Papageorgiou, John Meletis, Panayiotis Panayiotidis, Sotirios Sachanas, Pantelis Tsirkinidis, Maria K. Angelopoulou, Eleni Variami, Gerassimos A. Pangalis, Vassilios Telonis, Maria Moschogiannis, Marie-Christine Kyrtsonis, Marina P. Siakantaris, Theodoros P. Vassilakopoulos
Low absolute lymphocyte count (ALC) to absolute monocyte count (AMC) ratio (ALC/AMC) is an independent prognostic factor in Hodgkin lymphoma (HL), but different cutoffs (1.1, 1.5, and 2.9) have been applied. We aimed to validate the prognostic signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e9ad3de9471636f4ce7cffc403e52c
https://europepmc.org/articles/PMC4786349/
https://europepmc.org/articles/PMC4786349/
Autor:
Maria K. Angelopoulou, Flora N. Kontopidou, Christos Karkantaris, Antonia Giannakakis, Christos Kittas, P Korkolopoulou, Eleni Variamis, Konstantinos Anargyrou, Styliani I. Kokoris, Panayiotis Tsaftaridis, Maria N. Dimopoulou, Dimitrios Boutsis, Marina P. Siakantaris, Theodoros P. Vassilakopoulos, Marie-Christine Kyrtsonis, John Rombos, Gerassimos A. Pangalis
Publikováno v:
European Journal of Haematology. 68:289-298
Objectives: To investigate the prognosis of patients with Hodgkin's lymphoma (HL) who relapse following a complete remission (CR) achieved by chemotherapy with or without radiotherapy (CT±RT), and to identify prognostic factors for freedom from seco
Autor:
Styliani I. Kokoris, Flora N. Kontopidou, Gerassimos A. Pangalis, Marie-Christine Kyrtsonis, Maria N. Dimopoulou, Theodoros P. Vassilakopoulos, Penelope Korkolopoulou, Marina P. Siakantaris, Panayiotis Tsaftaridis, Evangelia M. Dimitriadou, Christina Kalpadakis, Eleni Plata, Maria K. Angelopoulou
Publikováno v:
Hematological oncology. 25(3)
Splenectomy has traditionally been considered as a standard first line treatment for splenic marginal zone lymphoma (SMZL) conferring a survival advantage over chemotherapy. However it carries significant complications, especially in elderly patients